日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of Computational Histology AI Biomarkers on Clinical Management Decisions in Non-Muscle Invasive Bladder Cancer: A Multi-Center Real-World Study

计算组织学人工智能生物标志物对非肌层浸润性膀胱癌临床管理决策的影响:一项多中心真实世界研究

Packiam, Vignesh T; Ghodoussipour, Saum; Konety, Badrinath R; Ahmadi, Hamed; Agarwal, Gautum; Kiedrowski, Lesli A; Krishna, Viswesh; Joshi, Anirudh; Williams, Stephen B; Smith, Armine K

Long-term outcomes of a cascading salvage strategy for high-risk non-muscle-invasive bladder cancer

高危非肌层浸润性膀胱癌级联挽救治疗策略的长期疗效

McElree, Ian M; Steinberg, Ryan L; Hougen, Helen Y; Mott, Sarah L; Packiam, Vignesh T; O'Donnell, Michael A

Drug-releasing intravesical floating technology for sequential gemcitabine and docetaxel in non-muscle-invasive bladder cancer

用于非肌层浸润性膀胱癌吉西他滨和多西他赛序贯治疗的药物缓释膀胱内漂浮技术

Rhodes, Ashley C; McClintic, Kaitlyn A; Witt, Emily; Nwosu, Ikenna; Balk, Kyle R; Reis, Colin; Sutton, Ian C; Bi, Jianling; Fu, Melinda Z; O'Donnell, Michael A; Packiam, Vignesh T; Byrne, James D

ASO Practice Guidelines Series: Surgical Management of Bladder Cancer Relapse

ASO实践指南系列:膀胱癌复发的外科治疗

Aydogdu, Can; McSweeney, Sean T; Packiam, Vignesh T; Bukavina, Laura

Sequential Intravesical Gemcitabine and Docetaxel for Non-Muscle Invasive Bladder Cancer: A Narrative Review Across Risk Groups

非肌层浸润性膀胱癌序贯膀胱内吉西他滨和多西他赛治疗:跨风险组的叙述性综述

Hemmati Ghavshough, Mahdi; Fu, Melinda Z; Islam, Raeesa; Patel, Disha; Ghodoussipour, Saum; Packiam, Vignesh T

Utility of blue-light cystoscopy and tumor-informed ctDNA for management of recurrent high-risk NMIBC with prostatic urethral involvement: A case report

蓝光膀胱镜检查和肿瘤信息ctDNA在复发性高危非肌层浸润性膀胱癌(伴前列腺尿道受累)管理中的应用:病例报告

Ghavshough, Mahdi Hemmati; Fu, Melinda Z; Sykes, Jennifer; Patel, Disha; Ghodoussipour, Saum; Packiam, Vignesh T

Presence of an Artificial Intelligence-powered Predictive Biomarker Is Associated with a Poor Response to Intravesical Bacillus Calmette-Guerin but Not to Intravesical Sequential Gemcitabine/Docetaxel in Patients with High-grade Non-muscle-invasive Bladder Cancer

在患有高级别非肌层浸润性膀胱癌的患者中,人工智能驱动的预测性生物标志物的存在与膀胱内卡介苗治疗反应不良相关,但与膀胱内序贯吉西他滨/多西他赛治疗反应不良无关。

Packiam, Vignesh T; McElree, Ian M; Ghodoussipour, Saum; Nimgaonkar, Vivek; Krishna, Viswesh; Kim, Joon Kyung; Allison, Derek B; Richards, Jordan R; Anand Rajan, K D; Chen, Stephanie J; Lotan, Yair; Williams, Stephen B; Zhang, Haochen; Watson, Drew; Vrabac, Damir; Abuzeid, Waleed M; Joshi, Anirudh; Kamat, Ashish M; O'Donnell, Michael A; Hensley, Patrick J

National Surgical Quality Improvement Program audit of contemporary perioperative care for radical cystectomy

国家外科质量改进计划对根治性膀胱切除术的当代围手术期护理进行审核

Pfail, John; Capellan, Jasmin; Passarelli, Rachel; Kaldany, Alain; Chua, Kevin; Lichtbroun, Benjamin; Srivastava, Arnav; Golombos, David; Jang, Thomas L; Pitt, Henry A; Packiam, Vignesh T; Ghodoussipour, Saum

Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancer

膀胱保留治疗与根治性膀胱切除术治疗BCG无反应性非肌层浸润性膀胱癌的长期疗效比较

Taylor, Jacob I; Kamat, Ashish M; O'Donnell, Michael A; Annapureddy, Drupad; Howard, Jeffrey; Tan, Wei Shen; McElree, Ian; Davaro, Facundo; Yim, Kendrick; Harrington, Stephen; Dyer, Elizabeth; Black, Anna J; Kanabur, Pratik; Roumiguié, Mathieu; Lerner, Seth; Black, Peter C; Raman, Jay D; Preston, Mark A; Steinberg, Gary; Huang, William; Li, Roger; Packiam, Vignesh T; Woldu, Solomon L; Lotan, Yair

Assessing the efficacy and safety of sequential intravesical gemcitabine and docetaxel - does time from transurethral resection of bladder tumour to induction matter?

评估序贯膀胱内吉西他滨和多西他赛的疗效和安全性——从经尿道膀胱肿瘤切除术到诱导治疗的时间是否重要?

McElree, Ian M; Henning, Grant M; Steinberg, Ryan L; Hougen, Helen Y; Mott, Sarah L; O'Donnell, Michael A; Packiam, Vignesh T